Of note, most of the NPC patients expressing TSG∆154-1054 exhibited distinctively higher serum titers of anti-VCA IgA (≥40) and anti-VCA IgG (≥1280) as compared to those who were TSG∆154-1054-negative (p < 0.03, p < 0.0001; Figure 5a,b). Here, CD79A is linked to nasopharyngeal carcinoma.